HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sex steroids, precursors, and metabolite deficiencies in men with isolated hypogonadotropic hypogonadism and panhypopituitarism: a GCMS-based comparative study.

AbstractCONTEXT:
Both testicular and adrenal steroid secretions are impaired in men with panhypopituitarism (Hypo-Pit), whereas only testicular steroid secretion is impaired in men with isolated gonadotropin deficiency (IHH) caused by normosmic congenital hypogonadotropic hypogonadism or Kallmann syndrome.
OBJECTIVE:
The objective of the study was to compare the serum levels of sex steroids, precursors, and metabolites between men with complete IHH and those with Hypo-Pit.
PATIENTS:
We studied 42 healthy men, 16 untreated men with IHH (normosmic congenital hypogonadotropic hypogonadism/Kallmann syndrome) and 23 men with Hypo-Pit (14 with craniopharyngioma, 9 with congenital hypopituitarism) receiving hydrocortisone, thyroxine, and GH replacement therapy but not T.
METHODS:
Gas chromatography/mass spectrometry (GCMS) was used to measure the serum levels of sex steroids [T, dihydrotestosterone (DHT), and estradiol (E2)], their precursors (pregnenolone, 17-hydroxypregnenolone, dehydroepiandrosterone, androstenediol, progesterone, 17-hydroxyprogesterone, and androstenedione), and their metabolites (androsterone, estrone, and estrone sulfate) as well as pregnenolone and dehydroepiandrosterone sulfate esters.
RESULTS:
All the above-mentioned steroids, and notably T, DHT, and E2, were significantly lower in IHH patients than in controls but remained well above the detection limit of the relevant assays. In Hypo-Pit men, all these steroids were dramatically and significantly lower than in IHH. Interestingly, T, DHT, and E2, as well as pregnenolone and dehydroepiandrosterone sulfate esters, were undetectable or barely detectable in the Hypo-Pit men.
CONCLUSIONS:
Steroid deficiencies are marked but partial in men with complete IHH. In contrast, men with Hypo-Pit have a very severe overall steroid deficiency. These deficiencies could affect health and quality of life.
AuthorsFrank Giton, Séverine Trabado, Luigi Maione, Julie Sarfati, Yves Le Bouc, Sylvie Brailly-Tabard, Jean Fiet, Jacques Young
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 100 Issue 2 Pg. E292-6 (Feb 2015) ISSN: 1945-7197 [Electronic] United States
PMID25393641 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dihydrotestosterone
  • Estrone
  • Testosterone
  • Androstenedione
  • Dehydroepiandrosterone
  • Progesterone
  • Estradiol
Topics
  • Adult
  • Androstenedione (blood)
  • Chromatography, Gas
  • Dehydroepiandrosterone (blood)
  • Dihydrotestosterone (blood)
  • Estradiol (blood)
  • Estrone (blood)
  • Humans
  • Hypogonadism (blood, drug therapy)
  • Hypopituitarism (blood, drug therapy)
  • Male
  • Mass Spectrometry
  • Progesterone (blood)
  • Testosterone (blood)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: